LONN.SW · EBS · Healthcare
Lonza Group AG
Also onConsensus Drift
Implied value per share
CHF 316.06
Market price
CHF 545.60
Implied upside
-42.1%
5-year forecast · Perpetuity growth terminal value · Mid-year discounting · Base case
Value Per Share
Same forecast, different terminal treatment. Percentages vs price.
Forecast Cashflows
Reporting currency (CHF). Outflows negative.
| Line | FY26 | FY27 | FY28 | FY29 | FY30 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | CHF 6.6bn | CHF 6.7bn | CHF 6.9bn | CHF 7.0bn | CHF 7.1bn | +1.6% |
| EBIT | CHF 1.2bn | CHF 1.2bn | CHF 1.2bn | CHF 1.2bn | CHF 1.3bn | +1.6% |
| NOPAT | CHF 1.0bn | CHF 1.0bn | CHF 1.0bn | CHF 1.1bn | CHF 1.1bn | +1.6% |
| Add depreciation & amortisation | CHF 714.8m | CHF 726.4m | CHF 738.2m | CHF 750.1m | CHF 762.3m | +1.6% |
| Less capital expenditure | CHF -1.7bn | CHF -1.7bn | CHF -1.7bn | CHF -1.8bn | CHF -1.8bn | +1.6% |
| Less increase in working capital | CHF 214.6k | CHF 218.1k | CHF 221.6k | CHF 225.2k | CHF 228.9k | -1.6% |
| Free cashflow to firm | CHF 32.8m | CHF 33.4m | CHF 33.9m | CHF 34.4m | CHF 35.0m | +1.6% |
| Discount factor | 0.9752 | 0.9275 | 0.8821 | 0.8389 | 0.7979 | - |
| Present value | CHF 32.0m | CHF 30.9m | CHF 29.9m | CHF 28.9m | CHF 27.9m | -3.4% |
| Present Value Of The Forecast | CHF 149.7m | |||||
Discount Rate
Source shown per component. All overridable above.
| Risk-free rate | 0.50% | CHF assumption - no free live source available for this market (assumption) |
| Equity risk premium | 5.50% | Market assumption |
| Beta | 0.894 | Reported 0.842, pulled toward 1.0 (Blume) |
| Cost of equity | 5.42% | Risk-free + beta x equity risk premium |
| Cost of debt | 3.37% | Interest expense / average total debt |
| Market capitalisation | CHF 38.1bn | 89.4% of capital |
| Total debt | CHF 4.5bn | 10.6% of capital, book value as a proxy |
| Tax rate | 15.0% | Effective, capped at statutory |
| WACC | 5.15% | E/V x Re + D/V x Rd x (1 - t) |
Terminal Value
Perpetuity growth is intrinsic. The exit multiple defaults to the company's current EV/EBITDA, so it answers a different question - what the shares are worth if today's rating holds and EBITDA grows as forecast.
Perpetuity growth at 2.50%
99% of EV
- Forecast FCFF, final year
- CHF 35.0m
- Capex at depreciation, working capital in reinvestment
- CHF 1.3bn
- Less reinvestment at g/ROIC (33.2% of NOPAT)
- CHF -416.6m
- Capitalised
- CHF 837.1m
- ROIC (reported)
- 7.5%
- Terminal value, undiscounted
- CHF 32.4bn
- Terminal value, discounted
- CHF 25.9bn
- Enterprise value
- CHF 26.0bn
- Less net debt
- CHF 3.8bn
- Equity value
- CHF 22.2bn
Exit at 19.3x EBITDA
100% of EV
- Terminal value, undiscounted
- CHF 39.2bn
- Terminal value, discounted
- CHF 31.3bn
- Enterprise value
- CHF 31.4bn
- Less net debt
- CHF 3.8bn
- Equity value
- CHF 27.6bn
Spread between methods: 22%.
Sensitivity
Value per share (CHF) by discount rate and long-run growth.
| Long-run growth | |||||
|---|---|---|---|---|---|
| Discount rate | 1.50% | 2.00% | 2.50% | 3.00% | 3.50% |
| 3.15% | 714.27 | 962.15 | 1591.93 | 6516.37 | — |
| 4.15% | 404.34 | 466.51 | 565.85 | 750.97 | 1220.94 |
| 5.15% | 265.13 | 286.70 | 316.06 | 358.66 | 426.55 |
| 6.15% | 186.39 | 194.18 | 203.85 | 216.32 | 233.15 |
| 7.15% | 135.95 | 138.03 | 140.37 | 143.06 | 146.25 |
Outlined: this model. Green text: above today's price of 545.60. Shading: distance from this model's own value.
Priced In
What each input would have to be to justify the current price, one at a time.
| Input | Model | Implied | Gap |
|---|---|---|---|
| Revenue growth, every year | 1.6% | 11.9% | +10.3pp |
| EBIT margin | 17.9% | 28.7% | +10.8pp |
| Discount rate | 5.1% | 4.2% | -0.9pp |
Live formulas, not pasted numbers - edit a driver and the workbook reprices.
Yahoo Finance and RBA data. General information, not advice. Methodology.